Table 3 Age and treatment adjusted risk of developing cognitive impairment or dementia by glucose group among the 4,961 women

Cognitive impairment outcomeGlucose groupNo. (%) of women with outcomeOR (95% CI)*
* Reference group for impaired fasting glucose (IFG) is participants with normal glucose (NG); reference group for diabetes is those participants with NG or IFG; reference group for trend model is those participants with NG, with the OR representing the change in one category of glucose status.
DementiaNG40 (0.9)
IFG3 (1.5)1.45 (0.44–4.76)
Diabetes5 (2.6)2.38 (0.92–6.12)
Trend1.55 (0.98–2.44)
MCING152 (3.3)
IFG8 (3.9)1.06 (0.51–2.20)
Diabetes13 (6.7)1.78 (0.99–3.20)
Trend1.29 (0.98–1.72)
Dementia, MCI, or Short Blessed Score >6NG273 (5.9)
IFG22 (10.1)1.64 (1.03–2.61)
Diabetes24 (12.1)1.79 (1.14–2.81)
Trend1.40 (1.14–1.72)